Category Archives: GCD-0032

Happy Birthday Lisa!

We could not have asked for better weather for Lisa’s birthday. The sun is out and the temperature should hit near 70! Perfect for a soak in the hot tub while enjoying the view of the mountain with its trees … Continue reading

Posted in GCD-0032, Uncategorized | 13 Comments

Positive Results for GDC-0032

A wonderful spring is on its way to the Granite State. The igloo has melted, the lake has thawed, and Lisa continues to respond well to her current treatment. She just started the fifth, 28-day cycle of GDC-0032 and the … Continue reading

Posted in GCD-0032, Uncategorized | 6 Comments

T-DM1 Receives FDA Approval

On February 22, 2012, the FDA approved Kadcyla, formerly know as T-DM1, for treatment of patients with HER2 positive breast cancer. Kadcyla is new type of targeted cancer treatment known as an antibody conjugate. It combines the antibody trastuzamab (Herceptin) … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 6 Comments

Happy 2013!

And good riddance to 2012! With steadfast fortitude and an unrelenting, positive attitude, Lisa survived that brutal year. Thanks to her talented medical team and the efficacy of the cutting edge treatments she has started out 2013 feeling better and … Continue reading

Posted in GCD-0032, Uncategorized | 5 Comments

Started on GDC-0032

Lisa has been taking GDC-0032 since last Friday (12/14/2012) and is feeling pretty good. GDC-0032 is a new drug in the fight against cancer. It works by blocking the PIK3 protein, which helps cancer cells grow. She is receiving this … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 5 Comments

Back Home and Doing OK

Just a quick update. After a one night stay at the hospital and lots of IV fluids, Lisa is back home. Yesterday afternoon she was able to eating solid food without a problem so there was no reason to keep … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 6 Comments

Good-bye T-DM1, Hello GDC-0032

Seasons change and so do cancer treatments. Lisa had a good run with T-DM1, a total of nine treatments over a six-month period, but the time has come for a change. T-DM1* worked well for Lisa, however, her CT scans … Continue reading

Posted in GCD-0032, T-DM1 & Systemic Treatment, Uncategorized | 5 Comments